|
Tuesday, March 23 — 1:00 PM — Salon 1 & Balconies
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section B - Breast Pathology
Chaired By: Ian Ellis and Sandra Shin
| Time | Title and Authors | Itinerary
Planner |
| 1:00 |
The Prognostic Benefit of the Histologic Grade for Breast Cancer after Integration into the TNM
(214)
DE Henson, D Chen, K Xing, AM Schwartz, L Pham, K Batich, AE Hart. - The George Washington University, Washington, DC; Uniform Services University of the Health Sciences, Bethesda, MD.
|  Add |
| 1:15 |
The Interaction between Mitotic Index and Bcl2 Expression Provides an Improved Separation Method for Determining Clinical Outcome Compared to Nottingham Histological Grading System (NGS)
(128)
TMA Abdel-Fatah, DG Powe, G Ball, JS Reis-Filho, AR Green, IO Ellis. - School of Molecular Medical Sciences and Nottingham University Hospitals Trust, University of Nottingham, Nottingham, United Kingdom; Nottingham Trent University, Nottingham, United Kingdom; Institute of Cancer Research, London, United Kingdom.
| Add |
| 1:30 |
Computer Aided Measurement of Tumor Area in Positive Lymph Nodes is an Alternative Way to Predict Prognosis of Metastatic Breast Cancer
(253)
Y Li, J Jackson, S Karan, P Rajan, A Salhadar, K Albequerque, CH Ersahin. - Loyola University Medical Center, Maywood, IL.
| Add |
| 1:45 |
Ki-67 Image Cytometric Quantitation and Oncotype Dx Recurrence Score in Estrogen Receptor-Positive Breast Cancer
(342)
DJ Williams, C Cohen, M Darrow, AJ Page, B Chastain, A Adams. - Emory University, Atlanta, GA.
| Add |
| 2:00 |
Distinction of Chemotherapy-Induced Epithelial Atypia from Minimal DCIS with Chemotherapy Effect in HER2 Positive Patients Using HER2 Immunostaining
(341)
KL White, YY Chen, JT Rabban. - UCSF, San Francisco, CA.
| Add |
| 2:15 |
The New Hormone Receptor Cutoff: For Defining Hormone Receptor Positivity What Is the Impact of the New 1% Cutoff Versus the Old 10% Cutoff on Hormone Receptor Concordance between Local IHC, Central IHC and Central RT—PCR?
(148)
FL Baehner, R Gray, B Childs, T Maddala, M Liu, S Rowley, N Davidson, S Shak, LJ Goldstein, GW Sledge, JA Sparano, S Badve. - University of California, San Francisco, San Francisco, CA; Genomic Health, Redwood City, CA; Eastern Cooperative Oncology Group, Indianapolis, IA; Sanofi Aventis, Bridgewater, NJ.
| Add |
| 2:30 |
Breast Hormonal Receptors Test should be repeated on excisional Biopsies after Negative Core Biopsy
(349)
S Zhang, Y Zakharia, W Tan, G Wilding, S Edge, W Liu, D Tan, T Khoury. - Roswell Park Cancer Institute, Buffalo; Unity Hospital, Rochester; MD Anderson Cancer Center, Houston.
| Add |
| 2:45 |
RECESS, EXHIBITS AND POSTER SESSION IV
| |
| 3:30 |
BUSINESS MEETING - Salon 1-3 & Balconies
| Add |
| 4:20 |
AWARD PRESENTATIONS
Stowell-Orbison, Autopsy, Surgical Pathology, Castleman and Vogel Awards
Distinguished Pathologist Award - Juan Rosai
F.K. Mostofi Distinguished Service Award - John Eble & James Crawford
President's Award - Jeffrey L. Myers
Ramzi Cotran Young Investigator Award - Jorge Reis-Filho
| Add |
| 5:00 |
MAUDE ABBOTT LECTURE - Henry D. Appelman
Bowels are Beautiful ........ and Profitable. The Gut Has Been Good to Me and I Am Grateful
| Add |
| 6:00 |
WINE and CHEESE RECEPTION - Thurgood Ballroom
| Add |
|
|
